PDS Biotechnology CorporationPDSBNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank62
3Y CAGR+2.2%
5Y CAGR+13.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+2.2%/yr
vs -3.8%/yr prior
5Y CAGR
+13.4%/yr
Recent deceleration
Acceleration
+6.0pp
Accelerating
Percentile
P62
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$13.06M-4.6%
2024$13.70M-10.4%
2023$15.28M+24.8%
2022$12.24M+20.2%
2021$10.18M+46.0%
2020$6.98M-25.1%
2019$9.31M-34.8%
2018$14.29M-19.1%
2017$17.66M+20.2%
2016$14.69M-